249 related articles for article (PubMed ID: 6334466)
1. [Significance of antinuclear anti-histone antibodies].
Ferec C; Youinou P; Le Goff P; Miossec P; Morin JF; Pennec Y; Morin PP; Le Menn G
Ann Med Interne (Paris); 1984; 135(6):427-30. PubMed ID: 6334466
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
3. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
4. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA.
Gripenberg M; Helve T; Kurki P
J Rheumatol; 1985 Oct; 12(5):934-9. PubMed ID: 3878880
[TBL] [Abstract][Full Text] [Related]
5. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
6. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
7. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
Yamagata H; Akizuki M; Tojo T; Homma M
Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
[TBL] [Abstract][Full Text] [Related]
8. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
9. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
10. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
11. [IgG-type antihistone antibodies. Diagnostic value in rheumatoid polyarthritis, scleroderma, spontaneous and drug-induced lupus].
Meyer O; Cyna L; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 Jun; 51(6):303-10. PubMed ID: 6382565
[TBL] [Abstract][Full Text] [Related]
12. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
Mahler M; Fritzler MJ; Blüthner M
Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
[TBL] [Abstract][Full Text] [Related]
13. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
14. Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis.
Bernstein RM; Hobbs RN; Lea DJ; Ward DJ; Hughes GR
Arthritis Rheum; 1985 Mar; 28(3):285-93. PubMed ID: 3872129
[TBL] [Abstract][Full Text] [Related]
15. The clinical application of an ELISA technique for the detection of antihistone antibodies.
Epstein A; Greenberg M; Halbert S; Kramer L; Barland P
J Rheumatol; 1986 Apr; 13(2):304-7. PubMed ID: 3522897
[TBL] [Abstract][Full Text] [Related]
16. [Natural biological models of autoimmune diseases].
Pleskovskaia GN
Revmatologiia (Mosk); 1991; (4):38-44. PubMed ID: 1805332
[No Abstract] [Full Text] [Related]
17. [Among the antinuclear antibodies in rheumatoid polyarthritis: antihistone antibodies detected by an immunoenzymatic technic].
Le Goff P; Muller S; Lelong A; Jouquan J; Youinou P
Rev Rhum Mal Osteoartic; 1988 Nov; 55(11):919-22. PubMed ID: 3264618
[No Abstract] [Full Text] [Related]
18. [Study on anti-histone fraction antibodies in patients with rheumatic diseases].
Jiang M; He K; Yan CL
Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):287-9, 317-8. PubMed ID: 1478127
[TBL] [Abstract][Full Text] [Related]
19. [Anticardiolipin antibodies in connective tissue diseases].
Cerda C; Neira O; Palma S; Abumohor P; Basualdo J; Alvarado MA; Guzmán L
Rev Med Chil; 1992 Mar; 120(3):239-43. PubMed ID: 1342474
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.
Meliconi R; Bestagno M; Sturani C; Negri C; Galavotti V; Sala C; Facchini A; Ciarrocchi G; Gasbarrini G; Astaldi Ricotti GC
Clin Exp Immunol; 1989 May; 76(2):184-9. PubMed ID: 2547538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
